APA

Kang C., Xia L., Chen Y., Zhang T., Wang Y., Zhou B., You M., Yuan Q., Tzeng C., An Z., Luo W. & Xia N. (20181126). A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys. : Protein & cell.

Chicago

Kang Ciming, Xia Lin, Chen Yuanzhi, Zhang Tianying, Wang Yiwen, Zhou Bing, You Min, Yuan Quan, Tzeng Chi-Meng, An Zhiqiang, Luo Wenxin and Xia Ningshao. 20181126. A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys. : Protein & cell.

Harvard

Kang C., Xia L., Chen Y., Zhang T., Wang Y., Zhou B., You M., Yuan Q., Tzeng C., An Z., Luo W. and Xia N. (20181126). A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys. : Protein & cell.

MLA

Kang Ciming, Xia Lin, Chen Yuanzhi, Zhang Tianying, Wang Yiwen, Zhou Bing, You Min, Yuan Quan, Tzeng Chi-Meng, An Zhiqiang, Luo Wenxin and Xia Ningshao. A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys. : Protein & cell. 20181126.